<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>LAURUSLABS on Financial Report Insights</title>
    <link>https://reports.muthu.co/tags/lauruslabs/</link>
    <description>Recent content in LAURUSLABS on Financial Report Insights</description>
    <generator>Hugo</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 28 Apr 2025 19:13:24 +0000</lastBuildDate>
    <atom:link href="https://reports.muthu.co/tags/lauruslabs/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Laurus Labs Ltd - Apr 2025 Earnings Call Transcript Analysis</title>
      <link>https://reports.muthu.co/posts/laurus-labs-ltd---apr-2025-earnings-call-transcript-analysis/</link>
      <pubDate>Mon, 28 Apr 2025 19:13:24 +0000</pubDate>
      <guid>https://reports.muthu.co/posts/laurus-labs-ltd---apr-2025-earnings-call-transcript-analysis/</guid>
      <description>&lt;h2 class=&#34;heading&#34; id=&#34;earnings-call-transcript-analysis-report&#34;&gt;&#xA;  Earnings Call Transcript Analysis Report&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#earnings-call-transcript-analysis-report&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h2 class=&#34;heading&#34; id=&#34;financial-performance&#34;&gt;&#xA;  Financial Performance&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#financial-performance&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;key-metrics&#34;&gt;&#xA;  Key Metrics:&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#key-metrics&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY25 Revenue:&lt;/strong&gt; INR 5,554 crores (+10% YoY)&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Q4 FY25 Revenue:&lt;/strong&gt; INR 1,720 crores (+19% YoY)&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY25 Gross Margin:&lt;/strong&gt; Maintained around 55% (Q4: 54.5%, FY25: 55.4%)&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY25 EBITDA Margin:&lt;/strong&gt; 20.1% (expanded by 4 percentage points YoY). Q4 EBITDA Margin: 27.7% (INR 477 crores).&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;FY25 Profit After Tax (PAT):&lt;/strong&gt; INR 258 crores (+122% YoY). Q4 PAT: INR 234 crores.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;ROCE:&lt;/strong&gt; Improved to 9.7% from 6.4% YoY.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Capex:&lt;/strong&gt; FY25: INR 659 crores (Q4: INR 211 crores). Majority invested in CDMO/CMO projects.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Net Debt:&lt;/strong&gt; INR 2,594 crores. Net Debt/EBITDA improved to 2.3x from 3.1x YoY.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;comparison&#34;&gt;&#xA;  Comparison:&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#comparison&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;p&gt;Strong finish to FY25 with significant YoY growth in Q4 revenue and PAT. Full-year revenue growth was modest at 10%, but profitability improved markedly with EBITDA margins expanding and PAT more than doubling. Gross margins remained stable and healthy.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Laurus Labs Ltd:Annual Report 2023-24 Analysis</title>
      <link>https://reports.muthu.co/posts/laurus-labs-ltdannual-report-2023-24-analysis/</link>
      <pubDate>Tue, 18 Jun 2024 19:21:03 +0000</pubDate>
      <guid>https://reports.muthu.co/posts/laurus-labs-ltdannual-report-2023-24-analysis/</guid>
      <description>&lt;h2 class=&#34;heading&#34; id=&#34;laurus-labs-ltd-a-comprehensive-overview&#34;&gt;&#xA;  Laurus Labs Ltd.: A Comprehensive Overview&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#laurus-labs-ltd-a-comprehensive-overview&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h2&gt;&#xA;&lt;h3 class=&#34;heading&#34; id=&#34;about-the-company&#34;&gt;&#xA;  About the Company&#xA;  &lt;a class=&#34;anchor&#34; href=&#34;#about-the-company&#34;&gt;#&lt;/a&gt;&#xA;&lt;/h3&gt;&#xA;&lt;p&gt;&lt;strong&gt;Year of Establishment and Founding History:&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;Laurus Labs was founded in 2005 by Dr. Satyanarayana Chava.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Headquarters Location and Global Presence:&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;The company&amp;rsquo;s headquarters are located in Hyderabad, India. Laurus Labs has a global presence with operations and partnerships across North America, Europe, and Asia.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Company Vision and Mission:&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&lt;strong&gt;Vision:&lt;/strong&gt; To be a leading, integrated research-driven pharmaceutical and biotechnology company.&lt;/li&gt;&#xA;&lt;li&gt;&lt;strong&gt;Mission:&lt;/strong&gt; To accelerate discovery, development, and manufacturing of affordable healthcare solutions.&lt;/li&gt;&#xA;&lt;/ul&gt;&#xA;&lt;p&gt;&lt;strong&gt;Key Milestones in Their Growth Journey:&lt;/strong&gt;&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
